ICU Medical, Inc. Financial Ratios — ICUI Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	15.88	12.78	11.11	6.63	10.39	12.95	12.41	4.76	15.01	11.32	11.96	-8.47	-3.59	-15.66	0.11
Return on Assets (%)	13.27	10.46	8.71	5.06	7.7	9.48	6.24	1.87	6.16	5.03	5.66	-2.32	-0.67	-2.74	0.02
Return on Capital (%)	15.88	12.78	11.11	6.63	10.4	12.97	- -	- -	14.68	10.9	11.4	- -	- -	- -	1.93
Return on Invested Capital (%)	10.96	11.5	9.56	6.01	9.72	11.83	- -	- -	9.29	8.21	7.39	- -	- -	- -	1.37
Gross Margin (%)	47.11	49.39	49.32	48.96	52.92	53.09	32.96	40.72	37.27	36.31	37.34	30.6	32.75	34.62	36.84
EBITDA Margin (%)	22.1	25.33	23.21	20.56	29.25	31.12	10.77	16.45	17.17	17.4	17.55	10.16	12.24	13.3	13.9
Operating Margin (%)	16.04	19.34	17	14.27	23.96	26.1	5.62	11.11	11.1	10.67	10.73	-0.16	2.12	4.09	4.9
Incremental Operating Margin (%)	4.28	87.21	252.36	206.22	116.44	45.49	-2.88	77.14	11.22	-103.48	12.61	- -	-246.29	40.33	-7.91
Pretax Margin (%)	21.98	19.52	16.8	12.87	20.4	22.45	3.97	1.6	9.06	7.67	9.36	-5.02	-3.47	-2.77	0.2
Profit Margin (%)	14.78	13.03	12.88	8.52	13.17	16.63	5.31	2.06	7.98	6.83	7.84	-3.26	-1.31	-4.94	0.03
Net Income to Common Margin (%)	14.78	13.03	12.88	8.52	13.17	16.63	5.31	2.06	7.98	6.83	7.84	-3.26	-1.31	-4.94	0.03
Effective Tax Rate (%)	32.75	33.24	23.33	33.82	35.46	25.93	- -	- -	11.92	10.9	16.28	- -	- -	- -	55.92
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	15.88	12.78	11.11	6.63	10.39	12.95	12.41	4.76	15.01	11.32	11.96	-8.47	-3.59	-15.66	0.11

Credit (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	36	52	45	1,734	1,704	1,626	1,332
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	7	9	9	48	71	51	19
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	29	43	36	1,686	1,633	1,575	1,314
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	0.17	0.24	0.2	7.49	6.16	5.13	4.3
Net Debt/EBITDA	-1.49	-1.83	-3.1	-4.34	-3.36	-3.77	-2.08	-1.5	-1.24	-1.79	-2.39	6.24	4.97	4.02	3.15
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	0.26	0.38	0.32	-486.07	35.62	16.69	12.19
Net Debt/EBIT	-2.05	-2.4	-4.24	-6.25	-4.11	-4.5	-3.99	-2.22	-1.91	-2.92	-3.91	-404.87	28.73	13.08	8.93
EBITDA to Interest Expense	- -	- -	- -	- -	2,562.56	1,000.57	68.02	324.8	396.08	126.18	269.21	3.27	2.69	2.97	3.32
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	2,205.26	792.49	29.1	182.65	202.93	68.92	174.6	1.87	1.78	2.13	2.28
EBIT to Interest Expense	- -	- -	- -	- -	2,099.15	839.13	35.5	219.39	255.98	77.34	164.66	-0.05	0.47	0.91	1.17
Interest Expense	- -	- -	- -	- -	- -	- -	2	1	1	2	1	71	103	107	93
Common Equity/Total Assets	83.73	80.19	76.87	75.86	72.67	73.59	39.26	39.28	42.77	45.97	48.59	18.6	18.51	16.48	17.12
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	2.1	2.89	2.23	80.69	76.89	80.14	61.85
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	3.8	5.03	3.76	65.51	64.94	67.93	64.85
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	1.71	2.46	1.92	37.35	37.29	37.46	32.43
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	2.63	3.47	2.79	82.98	80.24	82.74	62.73
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	4.77	6.04	4.7	67.37	67.77	70.13	65.77
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	2.14	2.96	2.4	38.41	38.91	38.68	32.89
Net Debt to Equity	-31.07	-37.58	-48.64	-54.27	-57.97	-67.42	-24.21	-27.28	-19.51	-26.37	-34.21	69.12	64.73	64.84	45.99
Net Debt/Capital (%)	-49.11	-74.67	-142.99	-204.82	-281.69	-605.3	-97.48	-124.02	-54.67	-84.85	-136.12	61.07	60.82	63.4	56.86
EBITDA	67	80	73	64	100	118	139	230	217	221	231	232	277	317	310
EBITDA-CapEx	51	60	53	46	86	94	60	130	111	121	150	132	183	227	213
Operating Income (Loss)	48	61	53	44	82	99	73	156	141	136	141	-4	48	97	109

Liquidity (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	5.46	7.77	11.04	12.07	8.86	10.98	1.43	1.53	1.18	2.1	2.83	0.43	0.53	0.55	0.62
Current Ratio	8.88	11.18	14.67	15.06	11.85	14.04	4.11	3.72	3.55	4.71	5.13	2.5	2.53	2.59	2.39
Quick Ratio	6.94	9.45	12.73	13.43	10.21	12.46	2.49	2.39	2.06	2.83	3.45	0.93	0.91	0.91	1.03
CFO/Avg Current Liab	2.34	2.27	2.35	2.39	1.8	2.16	1.23	0.7	0.41	1	1.35	-0.18	0.34	0.39	0.34
Common Equity/Total Assets	83.73	80.19	76.87	75.86	72.67	73.59	39.26	39.28	42.77	45.97	48.59	18.6	18.51	16.48	17.12
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	2.1	2.89	2.23	80.69	76.89	80.14	61.85
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	3.8	5.03	3.76	65.51	64.94	67.93	64.85
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	1.71	2.46	1.92	37.35	37.29	37.46	32.43
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	2.63	3.47	2.79	82.98	80.24	82.74	62.73
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	4.77	6.04	4.7	67.37	67.77	70.13	65.77
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	2.14	2.96	2.4	38.41	38.91	38.68	32.89
CFO/Total Liabilities	159.09	176	188.23	201.95	136.72	201.96	51.7	49.8	32.34	85.21	101.07	-2.56	7.37	9.11	9.33
CFO/CapEx	4.08	3.26	3.37	3.77	4.61	3.66	1.94	1.59	0.96	2.22	3.3	-0.63	1.77	2.26	1.85
Altman's Z-Score	12.55	17.05	19.07	25.7	25.86	35.15	10.85	11.23	9.76	12.72	13.87	3.01	2.82	3.35	3.38

Working Capital (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	6.12	6.84	6.64	7.33	7.05	6.66	15.31	9.69	6.69	7.79	11.45	13.92	11.79	13.83	12.28
Days Sales Outstanding	59.59	53.39	54.94	49.79	51.76	54.84	23.84	37.67	54.56	46.85	31.89	26.22	30.96	26.39	29.72
Inventory Turnover	3.78	4.18	4.49	4.42	3.99	3.83	5.13	2.77	2.45	2.48	2.73	3.21	2.16	2.41	2.35
Days Inventory Outstanding	96.45	87.35	81.25	82.53	91.4	95.26	71.17	131.89	149.06	147.12	133.9	113.76	168.82	151.65	155.47
Accounts Payable Turnover	12.95	12.73	13.88	14.12	13.38	12.97	23.82	8.58	6.59	7.85	10.46	13.39	8.38	9.61	9.53
Accounts Payable Turnover Days	28.19	28.68	26.3	25.85	27.28	28.14	15.33	42.54	55.38	46.51	34.9	27.27	43.57	37.97	38.31
Cash Conversion Cycle	127.86	112.06	109.89	106.46	115.87	121.96	79.69	127.02	148.23	147.47	130.89	112.71	156.21	140.07	146.88
Inventory to Cash Days	-36.86	-33.96	-26.31	-32.74	-39.64	-40.41	-47.33	-94.21	-94.51	-100.26	-102.01	-87.53	-137.86	-125.27	-125.76
Inventories	40	36	34	37	44	49	289	311	338	315	290	696	709	585	616
Raw Materials	25	21	22	23	25	28	82	104	120	126	136	287	296	265	265
Work In Process	3	3	3	4	4	4	42	53	40	33	36	74	59	38	38
Finished Goods	12	13	10	10	15	16	164	154	178	155	118	335	354	282	312
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	623	867	936	1,252	1,787	2,382	4,237	4,683	3,860	4,484	5,033	3,759	2,403	3,784	3,515
- Cash & Cash Equivalents	100	147	226	276	336	445	290	345	269	396	553	209	254	309	308
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	36	52	45	1,734	1,704	1,626	1,332
Enterprise Value	463	640	639	905	1,410	1,937	3,936	4,301	3,604	4,126	4,511	5,280	3,852	5,102	4,540
Total Capital	302	344	384	410	456	519	588	623	760	863	959	2,574	2,514	2,319	2,026
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	4.77	6.04	4.7	67.37	67.77	70.13	65.77
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	0.01	0.01	0.01	0.33	0.44	0.32	0.29
EV/Sales	1.53	2.02	2.04	2.93	4.13	5.11	3.05	3.07	2.85	3.25	3.43	2.32	1.71	2.14	2.03
EV/EBITDA	6.93	7.98	8.77	14.23	14.11	16.41	28.27	18.68	16.57	18.65	19.53	22.8	13.93	16.1	14.64
EV/EBIT	9.54	10.45	11.98	20.5	17.22	19.57	54.17	27.65	25.64	30.43	31.93	- -	80.52	52.38	41.52
EV/Cash Flow to Firm	7.17	9.66	9.72	13.64	21.95	21.52	25.05	26.69	35.19	18.39	16.82	- -	18.78	12.95	20.54
EV/Free Cash Flow to Firm	5.76	7.4	7.5	10.78	18.04	16.91	16.62	16.42	17.29	12.71	12.91	63.48	12.89	10.54	14.28
Diluted Market Cap	637	897	973	1,281	1,860	2,542	4,505	4,960	4,032	4,631	5,170	3,759	2,403	3,784	3,553
Diluted Enterprise Value	538	750	747	1,006	1,524	2,097	4,215	4,615	3,799	4,287	4,662	5,284	3,852	5,102	4,577
EV per Share	33.44	45.03	43.5	59.21	88.97	119.82	200.7	210.89	174.69	197.34	212.71	221.22	159.89	209.19	184.24
TTM Sales	302	317	314	309	342	379	1,293	1,400	1,266	1,271	1,316	2,280	2,259	2,382	2,231
TTM EBITDA	67	80	73	64	100	118	139	230	217	221	231	232	277	317	310
TTM Operating Income	48	61	53	44	82	99	73	156	141	136	141	-4	48	97	109
TTM Cash Flow to Firm	64	66	66	66	64	90	157	161	102	224	268	-16	205	394	221
TTM Free Cash Flow to Firm	80	87	85	84	78	115	237	262	208	325	349	83	299	484	318

Multiples (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	7.93	10.36	11.42	15.27	23.81	22.21	19.24	19.01	19.39	14.33	14.82	101.04	9.25	12.86	12.83
EV/EBIT	9.54	10.45	11.98	20.5	17.22	19.57	54.17	27.65	25.64	30.43	31.93	- -	80.52	52.38	41.52
Enterprise Value	463	640	639	905	1,410	1,937	3,936	4,301	3,604	4,126	4,511	5,280	3,852	5,102	4,540
Low Price	35.38	43.51	53.01	54	79.44	85.56	127	210.94	148.89	158.01	183.39	128.9	78.28	86.8	107
EV/Sales	1.53	2.02	2.04	2.93	4.13	5.11	3.05	3.07	2.85	3.25	3.43	2.32	1.71	2.14	2.03
EV/EBITDA	6.93	7.98	8.77	14.23	14.11	16.41	28.27	18.68	16.57	18.65	19.53	22.8	13.93	16.1	14.64
Price/Earnings	13.94	20.99	23.15	47.53	39.73	37.76	61.72	162.65	38.21	51.62	48.8	- -	- -	- -	4,802.44
Price/Earnings Average	12.86	18.39	23.82	37.54	35.15	29.81	48.84	185.71	42.93	46.53	44.23	-58.96	-122.19	-27.13	4,631.7
Price/Earnings High	14.24	21.82	30.89	50.78	43.93	39.67	64.4	227.86	53.03	56.92	57.98	-80.88	-172.57	-40.67	5,907.88
Price/Earnings Low	10.96	14.99	19.26	31.34	27.99	21.93	36.29	149.41	30.4	38.03	37.71	-41.42	-63.59	-17.99	3,601.75
Price/Book Value	2.06	2.52	2.44	3.05	3.92	4.59	7.21	7.52	5.33	5.53	5.51	4.48	2.97	5.46	5.07
Price/Book Value Average	1.9	2.21	2.51	2.41	3.47	3.63	5.71	8.59	5.99	4.99	4.99	5.21	4.47	4.61	4.89
Price/Book Value High	2.1	2.62	3.25	3.26	4.34	4.83	7.52	10.53	7.4	6.1	6.54	7.15	6.32	6.91	6.24
Price/Book Value Low	1.62	1.8	2.03	2.01	2.76	2.67	4.24	6.91	4.24	4.07	4.26	3.66	2.33	3.06	3.8
Price/Tangible Book Value	2.02	2.28	2.06	2.5	3.25	3.77	4.07	4.18	3.4	3.53	3.64	-10.99	-10.94	-18.17	-370.51
Price/Tangible Book Value Average	1.87	2	2.12	1.98	2.88	2.97	3.22	4.78	3.82	3.18	3.3	-12.8	-16.5	-15.33	-357.34
Price/Tangible Book Value High	2.07	2.37	2.75	2.68	3.6	3.96	4.24	5.86	4.72	3.89	4.32	-17.56	-23.3	-22.98	-455.79
Price/Tangible Book Value Low	1.59	1.63	1.71	1.65	2.29	2.19	2.39	3.84	2.71	2.6	2.81	-8.99	-8.59	-10.16	-277.88
Price/Sales	2.06	2.73	2.98	4.05	5.23	6.28	3.28	3.34	3.05	3.53	3.82	1.65	1.06	1.59	1.58
Price/Sales Average	1.9	2.4	3.07	3.2	4.63	4.96	2.59	3.82	3.43	3.18	3.47	1.92	1.6	1.34	1.52
Price/Sales High	2.11	2.84	3.98	4.32	5.78	6.6	3.42	4.69	4.23	3.89	4.54	2.64	2.27	2.01	1.94
Price/Sales Low	1.62	1.95	2.48	2.67	3.68	3.65	1.93	3.07	2.43	2.6	2.95	1.35	0.83	0.89	1.18
Price/Cash Flow	9.65	13.08	14.24	18.87	27.84	26.49	27.44	29.23	37.87	20.13	18.81	-60.5	14.46	18.55	19.55
Price/Cash Flow Average	8.91	11.45	14.65	14.9	24.63	20.91	21.71	33.37	42.56	18.15	17.05	-70.5	21.8	15.65	18.85
Price/Cash Flow High	9.87	13.59	19	20.16	30.78	27.83	28.63	40.95	52.57	22.2	22.35	-96.71	30.79	23.46	24.05
Price/Cash Flow Low	7.59	9.34	11.85	12.44	19.61	15.38	16.13	26.85	30.14	14.83	14.54	-49.52	11.35	10.38	14.66
Price/Free Cash Flow Average	7.32	9.08	11.75	12.06	21.06	17.53	15.23	21.7	21.78	12.92	13.44	117.74	13.94	10.85	12.38
Price/Free Cash Flow High	8.11	10.77	15.23	16.31	26.33	23.33	20.08	26.63	26.91	15.8	17.61	161.51	19.69	16.27	15.79
Price/Free Cash Flow Low	6.24	7.4	9.5	10.07	16.77	12.89	11.32	17.46	15.43	10.56	11.45	82.7	7.26	7.19	9.62
EV/Sales Average	1.57	1.93	2.35	2.31	3.64	3.78	2.37	3.57	3.24	2.91	3.08	2.59	2.25	1.89	1.98
EV/Sales High	1.78	2.38	3.26	3.43	4.8	5.42	3.2	4.44	4.05	3.62	4.16	3.3	2.91	2.56	2.4
EV/Sales Low	1.29	1.49	1.76	1.78	2.7	2.47	1.7	2.83	2.24	2.33	2.57	2.02	1.48	1.44	1.64
EV/EBITDA Average	7.11	7.63	10.12	11.21	12.46	12.16	22	21.72	18.88	16.72	17.55	25.5	18.34	14.23	14.24
EV/EBITDA High	8.04	9.39	14.04	16.69	16.41	17.43	29.66	26.99	23.57	20.8	23.69	32.53	23.74	19.26	17.25
EV/EBITDA Low	5.84	5.88	7.59	8.64	9.23	7.95	15.81	17.18	13.06	13.38	14.64	19.87	12.06	10.84	11.81
EV/EBIT Average	9.79	9.99	13.82	16.15	15.21	14.5	42.14	32.16	29.21	27.28	28.7	-1,655.11	106.05	46.31	40.38
EV/EBIT High	11.07	12.3	19.18	24.05	20.03	20.78	56.84	39.96	36.47	33.94	38.73	-2,111.49	137.29	62.66	48.92
EV/EBIT Low	8.04	7.7	10.36	12.45	11.27	9.48	30.29	25.44	20.2	21.83	23.93	-1,289.83	69.73	35.26	33.48
Last Price	45	60.93	63.71	81.9	112.78	147.35	216	229.63	187.12	214.49	237.34	157.48	99.74	155.17	142.67
High Price	45.99	63.32	85	87.5	124.69	154.8	225.38	321.7	259.72	236.5	282	251.73	212.43	196.26	175.51
Enterprise Value Average	475	612	737	713	1,245	1,435	3,063	5,002	4,105	3,698	4,054	5,905	5,073	4,510	4,415
Enterprise Value High	537	754	1,022	1,061	1,640	2,058	4,130	6,216	5,125	4,601	5,472	7,534	6,567	6,104	5,349
Enterprise Value Low	390	472	553	549	923	938	2,201	3,957	2,839	2,960	3,381	4,602	3,335	3,434	3,661

Shares Outstanding	14	14	15	16	16	16	20	20	21	21	21	24	24	25	25
Diluted Weighted Avg Shares	14	15	15	16	16	17	21	22	22	22	22	24	24	24	25
Basic Weighted Avg Shares	14	14	15	15	16	16	20	20	21	21	21	24	24	24	25
Revenue per Share	21.84	22.28	21.36	20.24	21.56	23.46	65.9	68.65	61.38	60.79	62.07	95.53	93.77	97.67	90.55
EBITDA per Share	4.83	5.64	4.96	4.16	6.31	7.3	7.1	11.29	10.54	10.58	10.89	9.7	11.48	12.99	12.58
Operating Income per Share	3.5	4.31	3.63	2.89	5.17	6.12	3.71	7.63	6.81	6.48	6.66	-0.15	1.99	3.99	4.44
Basic EPS, GAAP	3.23	2.9	2.75	1.72	2.84	3.9	3.5	1.41	4.9	4.16	4.86	-3.11	-1.23	-4.83	0.03
Basic EPS from Cont Ops	3.23	2.9	2.75	1.72	2.84	3.9	3.5	1.41	4.9	4.16	4.86	-3.11	-1.23	-4.83	0.03
Diluted EPS, GAAP	3.15	2.8	2.65	1.68	2.73	3.66	3.29	1.33	4.69	4.02	4.74	-3.11	-1.23	-4.83	0.03
Diluted EPS from Cont Ops	3.15	2.8	2.65	1.68	2.73	3.66	3.29	1.33	4.69	4.02	4.74	-3.11	-1.23	-4.83	0.03
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	4.66	4.66	4.47	4.34	4.05	5.56	7.87	7.86	4.94	10.65	12.62	-2.6	6.9	8.37	7.3
Free Cash Flow per Basic Share	3.52	3.23	3.15	3.19	3.17	4.04	3.81	2.91	-0.2	5.85	8.79	-6.76	3.01	4.67	3.36
Cash & Equivalents per Share	11.56	15.9	20.21	22.69	23.81	27.53	15.3	18.74	14.19	19.65	26.75	8.92	10.57	12.65	12.5
Book Value per Share	21.85	24.16	26.15	26.86	28.74	32.08	29.96	30.54	35.09	38.78	43.1	35.19	33.63	28.4	28.14
Tangible Book Value per Share	22.24	26.68	30.96	32.7	34.67	39.1	53.13	54.87	55	60.84	65.28	-14.33	-9.12	-8.54	-0.39

ICU Medical, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)